Epoch Biodesign has appointed Jamie Scott as Chief Operating Officer as it expands manufacturing in Spain and prepares its nylon 6,6 recycling technology for commercial scale. Scott brings more than 30 years of chemical manufacturing, industrial operations and technology commercialisation experience to the British biotechnology company. He joins as Epoch develops a 52,000-tonne-per-year nylon 6,6 polymerisation facility in Blanes and constructs a London demonstration plant intended to process hundreds of tonnes of post-consumer waste each year. The appointment adds experienced industrial leadership at a key point in the company’s push to create circular nylon 6,6 materials.
Industrial Experience For Scale Up
Scott will report to Epoch founder and CEO Jacob Nathan, leading the company’s production operations and supply chain. His career includes roles at Koch Technology Solutions, INVISTA, Cristal, Huntsman and Centrica Storage, alongside leadership of INVISTA’s European nylon intermediates business.
The role centres on turning Epoch’s established technology development into manufacturing operations. Scott will oversee the Blanes site as conventional polymer production restarts later this month, while supporting progress towards the company’s first commercial recycling facility.
Jamie Scott, Chief Operating Officer at Epoch Biodesign, said:
“Epoch is at a pivotal moment, moving from technology demonstration to large-scale deployment, and I’m delighted to be joining now. What drew me to the business was its combination of truly differentiated technology and a credible route to building a scalable commercial business around it. I look forward to bringing my experience to Epoch’s next phase, from growing our operations in Blanes to progressing our first commercial recycling facility.”
Blanes Manufacturing Base
Epoch recently acquired the nylon 6,6 polymerisation facility in Blanes, Spain, which gives the business around 10% of Europe’s nylon 6,6 production capacity. Its 52,000-tonne annual capacity provides a sizeable industrial base as the company builds its recycling operations.
The site is intended to support a transition from conventional polymer production towards recycled material at commercial scale. Nylon 6,6 is widely used across sectors including textiles, automotive components and industrial applications, making reliable processing infrastructure central to a circular supply chain.
Epoch’s manufacturing expansion follows a wider strengthening of its senior team. Dr Bo Ava Chen joined as Chief Technology Officer in June, while former INVISTA CTO Jerry Grunewald serves as a senior adviser. In February 2026, Epoch also signed a memorandum of understanding with INVISTA to develop post-consumer recycled nylon 6,6 at commercial scale.
Demonstrating Enzymatic Recycling
Alongside its Spanish operations, Epoch has begun construction of a demonstration facility at Grapht Works, the advanced manufacturing hub of Imperial College London in North Acton. The plant is designed to process hundreds of tonnes of post-consumer nylon 6,6 waste annually.
Epoch says the facility will be Europe’s first and the world’s largest nylon 6,6 biorecycling plant. It will demonstrate the company’s approach to returning waste nylon 6,6 to its original monomers, adipic acid and hexamethylenediamine.
The company uses AI-engineered enzymes in a low-temperature process that it says can process difficult waste streams, including silicon-coated airbag fabric, elastane-blended textiles and post-consumer automotive components. These inputs can be difficult to manage through conventional recycling routes, yet represent potential feedstock for virgin-quality recycled materials.
Building Circular Nylon Supply
Epoch reports that more than three million tonnes of nylon 6,6 are produced globally each year, while less than 1% is recycled. Recovering its original chemical building blocks could allow material to be returned to production rather than lost at end of life.
Epoch has raised more than $50 million to support its scale-up, including a $12 million strategic funding round announced in March. Its backers include lululemon, Lowercarbon Capital, Extantia, KOMPAS and Inditex’s Mundi Ventures.
Jacob Nathan, Founder and CEO of Epoch Biodesign, said:
“Jamie’s appointment is an important milestone in Epoch’s growth, and I’m thrilled to welcome him to the team. His decades of experience across chemical manufacturing, global supply chains and technology commercialisation are exactly what Epoch needs. As we expand our industrial operations and move towards commercial-scale recycling, Jamie will play a central role in turning our momentum into the manufacturing capability needed to deliver circular nylon 6,6 at scale.”
A Commercialisation Milestone
Scott’s appointment gives Epoch experienced operational leadership as it combines technology development with a growing physical manufacturing footprint. With its Blanes facility, London demonstration plant and industry relationships, the company is assembling the capacity needed to move nylon 6,6 biorecycling from demonstration to commercial production.
